404 related articles for article (PubMed ID: 19243054)
1. Effect of superparamagnetic iron oxide on tumor-to-liver contrast at T2*-weighted gradient-echo MRI: comparison between 3.0T and 1.5T MR systems.
Kim T; Murakami T; Hori M; Onishi H; Tomoda K; Nakamura H
J Magn Reson Imaging; 2009 Mar; 29(3):595-600. PubMed ID: 19243054
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
[TBL] [Abstract][Full Text] [Related]
3. Tumor-liver contrast and subjective tumor conspicuity of respiratory-triggered T2-weighted fast spin-echo sequence compared with T2*-weighted gradient recalled-echo sequence for ferucarbotran-enhanced magnetic resonance imaging of hepatic malignant tumors.
Ishiyama K; Hashimoto M; Izumi J; Watarai J; Shibata S; Sato T; Yamamoto Y
J Magn Reson Imaging; 2008 Jun; 27(6):1322-6. PubMed ID: 18504744
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
[TBL] [Abstract][Full Text] [Related]
5. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions.
Namkung S; Zech CJ; Helmberger T; Reiser MF; Schoenberg SO
J Magn Reson Imaging; 2007 Apr; 25(4):755-65. PubMed ID: 17335040
[TBL] [Abstract][Full Text] [Related]
6. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
[TBL] [Abstract][Full Text] [Related]
7. Gradient- and spin-echo T2-weighted imaging for SPIO-enhanced detection and characterization of focal liver lesions.
Yoshikawa T; Mitchell DG; Hirota S; Ohno Y; Oda K; Maeda T; Fujii M; Sugimura K
J Magn Reson Imaging; 2006 May; 23(5):712-9. PubMed ID: 16568431
[TBL] [Abstract][Full Text] [Related]
8. [Detection of liver lesions with gadolinium-enhanced VIBE sequence in comparison with SPIO-enhanced MRI].
Heim P; Steiner P; Schoder V; Dieckmann C; Kuhlencordt R; Adam G
Rofo; 2003 Oct; 175(10):1376-83. PubMed ID: 14556107
[TBL] [Abstract][Full Text] [Related]
9. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US.
Vogl TJ; Schwarz W; Blume S; Pietsch M; Shamsi K; Franz M; Lobeck H; Balzer T; del Tredici K; Neuhaus P; Felix R; Hammerstingl RM
Eur Radiol; 2003 Feb; 13(2):262-72. PubMed ID: 12598989
[TBL] [Abstract][Full Text] [Related]
10. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
Kim YK; Kim CS; Kwak HS; Lee JM
J Magn Reson Imaging; 2004 Nov; 20(5):826-37. PubMed ID: 15503325
[TBL] [Abstract][Full Text] [Related]
12. [Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors].
Vogl TJ; Schwarz W; Hammerstingl R; Kümmel S; Balzer JO; Mack MG; Diebold T; Balzer T; Shamsi K; Bechstein WO; Schrem H; Neuhaus P; Felix R
Rofo; 1997 Sep; 167(3):264-73. PubMed ID: 9376555
[TBL] [Abstract][Full Text] [Related]
13. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
Lee JM; Kim CS; Youk JH; Lee MS
Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629
[TBL] [Abstract][Full Text] [Related]
14. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF
AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma in cirrhotic liver: double-contrast-enhanced, high-resolution 3.0T-MR imaging with pathologic correlation.
Yoo HJ; Lee JM; Lee MW; Kim SJ; Lee JY; Han JK; Choi BI
Invest Radiol; 2008 Jul; 43(7):538-46. PubMed ID: 18580337
[TBL] [Abstract][Full Text] [Related]
16. Detection of malignant hepatic tumors with ferumoxides-enhanced MRI: comparison of five gradient-recalled echo sequences with different TEs.
Matsuo M; Kanematsu M; Itoh K; Murakami T; Maetani Y; Kondo H; Goshima S; Kako N; Hoshi H; Konishi J; Moriyama N; Nakamura H
AJR Am J Roentgenol; 2004 Jan; 182(1):235-42. PubMed ID: 14684545
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
[TBL] [Abstract][Full Text] [Related]
18. Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide.
Mori K; Yoshioka H; Itai Y; Okamoto Y; Mori H; Takahashi N; Saida Y
AJR Am J Roentgenol; 2000 Dec; 175(6):1659-64. PubMed ID: 11090400
[TBL] [Abstract][Full Text] [Related]
19. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
Vogl TJ; Hammerstingl R; Keck H; Felix R
Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
[TBL] [Abstract][Full Text] [Related]
20. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence.
Abe Y; Yamashita Y; Namimoto T; Tang Y; Takahashi M
Radiat Med; 2000; 18(2):97-105. PubMed ID: 10888042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]